Cargando…

ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature

Driver mutations involving tyrosine kinase receptors play crucial roles in the oncogenesis of lung adenocarcinoma. However, receptor tyrosine kinase mutations are extremely rare events in primary pulmonary neuroendocrine carcinoma (NEC), which is a molecular heterogeneous entity. In this study, we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qiang, Zheng, Mingjia, Jin, Yan, Shen, Xuxia, Shan, Ling, Shen, Lei, Sun, Yihua, Chen, Haiquan, Li, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103612/ https://www.ncbi.nlm.nih.gov/pubmed/30154667 http://dx.doi.org/10.2147/OTT.S172124

Ejemplares similares

ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
por: Li, Yuan, et al.
Publicado: (2013)

Oesophageal neuroendocrine tumours—case series of a rare malignancy
por: Nikolic, Amanda L, et al.
Publicado: (2022)

Primary Squamous Cell Carcinoma of the Liver is Rare but Hostile: Case Series and Comprehensive Review of the Literature
por: Xiao, Junjuan, et al.
Publicado: (2021)

Rare Vulvar Angiomyofibroblastoma: Case Series and Literature Review
por: Chen, Ling, et al.
Publicado: (2023)

Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review
por: Chen, Qin, et al.
Publicado: (2023)

Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases
por: Zhu, Viola W, et al.
Publicado: (2020)

Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report
por: Huang, Jie, et al.
Publicado: (2022)

Hematidrosis: A rare entity – case series and review of literature
por: Biswas, Dipanwita, et al.
Publicado: (2022)

Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing
por: Zhang, Chenlu, et al.
Publicado: (2020)

Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis
por: Fu, Zaixiang, et al.
Publicado: (2022)

Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases
por: Shen, Xuxia, et al.
Publicado: (2018)

EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis
por: Cheng, Chao, et al.
Publicado: (2015)

Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
por: Shan, Ling, et al.
Publicado: (2014)

Current status and challenges of immunotherapy in ALK rearranged NSCLC
por: Qi, Rongbin, et al.
Publicado: (2022)

Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib
por: Hayashi, Nobuyoshi, et al.
Publicado: (2017)

EML4-ALK rearrangement of lung large cell neuroendocrine carcinoma: a case report
por: Chen, Dianjun, et al.
Publicado: (2023)

Three rare etiologies of urinary retention in pediatrics: A case series and review of the literature
por: Hekmati, Pooya, et al.
Publicado: (2023)

Parameatal urethral cyst: A case series of three rare cases and literature review
por: Maliki, Ahmad, et al.
Publicado: (2023)

Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
por: Fang, Shen-Cun, et al.
Publicado: (2017)

A rare presentation of POEMS syndrome on magnetic resonance neurography: a case series
por: Su, Xiaoyun, et al.
Publicado: (2022)

Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases
por: Kuang, Muyu, et al.
Publicado: (2018)

Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review
por: Ji, Wei, et al.
Publicado: (2021)

Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series
por: Takahara, Yutaka, et al.
Publicado: (2022)

Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
por: Takeyasu, Yuki, et al.
Publicado: (2021)

Targeting ALK Rearrangements in NSCLC: Current State of the Art
por: Peng, Ling, et al.
Publicado: (2022)

Femoral Head Necrosis Due to Brucella Infection in China: Case Series and Literature Review
por: Wang, Jie, et al.
Publicado: (2022)

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020)

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
por: Cha, Yoon Jin, et al.
Publicado: (2016)

A case series of a rare tendon rupture
por: Weber, Sabrina, et al.
Publicado: (2021)

A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib
por: Lim, Chloe A., et al.
Publicado: (2022)

Pseudocirrhosis: A Case Series and Literature Review
por: Adike, Abimbola, et al.
Publicado: (2016)

Rhabdomyosarcoma in Adults: Case Series and Literature Review
por: Chen, Jian, et al.
Publicado: (2022)

Syringocystadenoma papilliferum: case series and review of the literature
por: Gorji, Leva, et al.
Publicado: (2023)

Chromoblastomycosis: A Case Series and Literature Review
por: Shenoy, Manjunath M., et al.
Publicado: (2023)

ALK-rearranged squamous cell carcinoma of the lung
por: Takanashi, Yusuke, et al.
Publicado: (2015)

Endometrial cancer with an EML4-ALK rearrangement
por: Craig, Jeffrey W., et al.
Publicado: (2018)

ALK‐rearranged squamous cell carcinoma of the lung
por: Meng, Qiyi, et al.
Publicado: (2021)

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
por: Zheng, Shanbo, et al.
Publicado: (2015)

Targeting ALK in Neuroendocrine Tumors of the Lung
por: Akhoundova, Dilara, et al.
Publicado: (2022)

Sweyjawbu expression is a predictor of ALK rearrangement status in lymphoma
por: Xue, Kai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_78dnb52en5nfpbar7f9val2utl